Opicapone Use in Clinical Practice across Germany: A Sub-Analysis of the OPTIPARK Study in Parkinson’s Disease Patients with Motor Fluctuations

医学 左旋多巴 队列 帕金森病 评定量表 物理疗法 德国的 内科学 疾病 心理学 历史 发展心理学 考古
作者
Heinz Reichmann,Karla Eggert,Christian Oehlwein,Tobias Warnecke,Andrew J. Lees,Michael Kemmer,Patrício Soares‐da‐Silva
出处
期刊:European Neurology [Karger Publishers]
卷期号:85 (5): 389-397 被引量:2
标识
DOI:10.1159/000523771
摘要

<b><i>Introduction:</i></b> The OPTIPARK study confirmed the effectiveness and safety of opicapone as adjunct therapy to levodopa in patients with Parkinson’s disease (PD) and motor fluctuations under real-world conditions. The aim of this sub-analysis was to evaluate opicapone in the German patient cohort of OPTIPARK in order to provide country-specific data. <b><i>Methods:</i></b> OPTIPARK was an open-label, single-arm study conducted in routine clinical practice across Germany and the UK. Patients with PD and motor fluctuations received once-daily opicapone 50 mg for 3 months in addition to levodopa. The primary endpoint was Clinicians’ Global Impression of Change (CGI-C). Secondary assessments included Patients’ Global Impressions of Change (PGI-C), Unified Parkinson’s Disease Rating Scale (UPDRS) I–IV, Parkinson’s Disease Questionnaire (PDQ-8), and Non-Motor Symptoms Scale (NMSS). This sub-analysis reports outcomes from the German patients only. <b><i>Results:</i></b> Overall, 363 (97.6%) of the 372 patients included in the German cohort received ≥1 dose of opicapone and 291 (80.2%) completed the study. Improvements on CGI-C and PGI-C were reported by 70.8% and 76.3% of patients, respectively. UPDRS scores improved for activities of daily living during OFF time by −3.3 ± 4.5 points and motor scores during ON time by −5.3 ± 7.9 points. PDQ-8 and NMSS scores also demonstrated improvements. Treatment emergent adverse events considered at least possibly related to opicapone occurred in 37.7% of patients, with most being of mild or moderate intensity. <b><i>Conclusion:</i></b> Opicapone added to levodopa in patients with PD and motor fluctuations was effective and generally well tolerated in routine clinical practice across Germany.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
奶黄包完成签到 ,获得积分10
1秒前
袁小二完成签到 ,获得积分10
1秒前
舒适鸣凤的应助被777采纳,获得10
1秒前
快乐乐巧发布了新的文献求助10
1秒前
梦比优斯酱完成签到,获得积分20
1秒前
2秒前
小二郎的应助被独特绝义采纳,获得10
2秒前
墨白发布了新的文献求助10
2秒前
西柏发布了新的文献求助30
4秒前
fa完成签到,获得积分10
5秒前
Nole的应助被LSY采纳,获得10
5秒前
bkagyin的应助被LSY采纳,获得10
5秒前
可爱的函函的应助被LSY采纳,获得10
5秒前
6秒前
6秒前
skip发布了新的文献求助10
7秒前
8秒前
8秒前
9秒前
Owen的应助被认真磐采纳,获得10
9秒前
9秒前
10秒前
10秒前
小二郎的应助被梦寐寤寐采纳,获得10
11秒前
llllllll完成签到,获得积分10
11秒前
11秒前
jingggggg完成签到,获得积分10
11秒前
12秒前
12秒前
香蕉觅云的应助被xxn采纳,获得10
12秒前
12秒前
orixero的应助被徐枘采纳,获得10
12秒前
如果天气好的话完成签到 ,获得积分10
12秒前
12秒前
13秒前
桐桐的应助被科研助理795采纳,获得10
13秒前
Ornn完成签到,获得积分10
13秒前
13秒前
liuliu_发布了新的文献求助10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193335
求助须知:如何正确求助?哪些是违规求助? 9579489
关于积分的说明 21865844
捐赠科研通 7792843
什么是DOI,文献DOI怎么找? 3437210
关于科研通互助平台的介绍 2560687
邀请新用户注册赠送积分活动 2483996